Novartis to Leave Joint Venture with Aventis

Mar 14, 2011, 11:00 IST

Novartis Pharma AG is to acquire 49% stake in Chiron Behring Vacccines Pvt Ltd. for 22.3 million US dollars from Aventis Pharma Ltd.

Novartis Pharma AG is to acquire 49% stake in Chiron Behring Vacccines Pvt Ltd. for 22.3 million US dollars from Aventis Pharma Ltd. Chiron Behring is a joint venture of Novartis vaccines & diagnostics Inc. and Aventis Pharma.


Aventis Pharma is the Indian arm of French multinational drug maker Sanofi Aventis.

Jagran Josh
Jagran Josh

Education Desk

    Your career begins here! At Jagranjosh.com, our vision is to enable the youth to make informed life decisions, and our mission is to create credible and actionable content that answers questions or solves problems for India’s share of Next Billion Users. As India’s leading education and career guidance platform, we connect the dots for students, guiding them through every step of their journey—from excelling in school exams, board exams, and entrance tests to securing competitive jobs and building essential skills for their profession. With our deep expertise in exams and education, along with accurate information, expert insights, and interactive tools, we bridge the gap between education and opportunity, empowering students to confidently achieve their goals.

    ... Read More
    Get here latest daily, weekly and monthly Current Affairs and GK in English and Hindi for UPSC, SSC, Banking, Railway, Defence and exams. Download Jagran Josh Current Affairs App.

    Take Weekly Tests on app for exam prep and compete with others. Download Current Affairs and GK app

    AndroidIOS

    Trending

    Latest Education News